A Study to Assess Efficacy and Safety of GLPG1972/S201086 in Participants With Knee Osteoarthritis
Status:
Completed
Trial end date:
2020-07-14
Target enrollment:
Participant gender:
Summary
This study is a phase 2, 52-week international, multi-regional, multi-center, randomized,
double-blind, placebo-controlled dose-ranging study for the treatment of osteoarthritis.